Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor

Computational and Structural Biotechnology Journal(2020)10.1016/j.csbj.2019.12.012Source: DataRank Database

The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor is a research paper published in Computational and Structural Biotechnology Journal (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

gen pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.97)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Hideaki Yano ORCID,Ming Xu ORCID,Leanne Liu,Sett Naing,Andrew D. Fant

Live enrichment

PubMed:32055286 PMC:PMC7005341 OpenAlex:https://openalex.org/W2999803872

Intramural NIH HHS

Grant: ZIA DA000606

National Institutes of Health

Grant: 1ZIADA000606-01

Structural basis for the functions of dopamine receptors and transporter

National Institutes of Health

FWCI

0.97

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.csbj.2019.12.012

publisherhttps://doi.org/10.1016/j.csbj.2019.12.012

publisherhttps://api.elsevier.com/content/article/PII:S2001037019303368?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2001037019303368?httpAccept=text/plain

publisherhttps://spj.science.org/doi/pdf/10.1016/j.csbj.2019.12.012

Fields of Study

Pharmacological Receptor Mechanisms and EffectsReceptor Mechanisms and SignalingNicotinic Acetylcholine Receptors Study0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Helix (gastropod)Transmembrane domainMutationBiophysicsMolecular dynamicsMutagenesisLigand (biochemistry)OligomerChemistryCyclic nucleotide-binding domainPoint mutationBiologyStereochemistryReceptorBiochemistryPeptide sequenceGeneWestern blotOligomerizationAmyotrophic Lateral SclerosisMolecular Dynamics SimulationsBioluminescence Resonance Energy TransferSigma 1 ReceptorTP248.13-248.65BiotechnologyResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor

FAIR Checklist

Authors (7)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)